PCG PHARMACIES AS

5179 GODVIK

Finances

Share Ownership

Return on Equity

157,27 %

Current Ratio

1,05

Debt-to-Equity Ratio

Key figures (NOK)	2022	2021	2020	2019
Revenue	23 809 000	22 819 000	21 693 000	16 767 000
Net Income	909 000	800 000	906 000	331 000
Total Assets	5 569 000	4 759 000	4 782 000	4 287 000
Total Equity	578 000	655 000	245 000	419 000

Income (NOK)	2022	2021	2020	2019
Revenue	23 809 000	22 819 000	21 693 000	16 767 000
Expenditure	22 641 000	21 794 000	20 531 000	16 343 000
Operating Profit	1 168 000	1 026 000	1 162 000	425 000
Financial Income	0	0	0	1 000
Financial Costs	1 000	0	1 000	1 000
Financial Balance	−1 000	0	−1 000	0
Earnings Before Tax	1 166 000	1 026 000	1 162 000	425 000
Tax	257 000	226 000	256 000	94 000
Net Income	909 000	800 000	906 000	331 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	328 000	445 000	597 000	708 000
Total Current Assets	5 241 000	4 315 000	4 185 000	3 579 000
Total Assets	5 569 000	4 759 000	4 782 000	4 287 000
Total Retained Equity	548 000	625 000	215 000	389 000
Total Equity	578 000	655 000	245 000	419 000
Total Long-Term Debt	0	0	0	1 310 000
Total Current Debt	4 992 000	4 104 000	4 537 000	2 557 000
Total Equity and Debt	5 569 000	4 759 000	4 782 000	4 287 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	23 809 000	22 819 000	21 693 000	16 767 000
Other Income	0	0	0	0
Revenue	23 809 000	22 819 000	21 693 000	16 767 000
Cost of Goods Sold	17 298 000	16 731 000	15 847 000	11 918 000
Salary Costs	3 943 000	3 902 000	3 590 000	3 466 000
Depreciation	138 000	152 000	159 000	162 000
Impairment	0	0	0	0
Expenditure	22 641 000	21 794 000	20 531 000	16 343 000
Operating Profit	1 168 000	1 026 000	1 162 000	425 000
Financial Income	0	0	0	1 000
Financial Costs	1 000	0	1 000	1 000
Financial Balance	−1 000	0	−1 000	0
Dividends	0	0	0	0
Net Income	909 000	800 000	906 000	331 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	74 000	53 000	54 000	5 000
Real Eastate	0	0	0	0
Machinery and Plant Facilities	176 000	257 000	338 000	419 000
Fixtures	28 000	85 000	156 000	235 000
Total Tangible Assets	204 000	342 000	494 000	653 000
Total Fiancial Fixed Assets	50 000	50 000	50 000	50 000
Total Fixed Assets	328 000	445 000	597 000	708 000
Stock	1 759 000	1 604 000	1 453 000	1 228 000
Total Investments	0	0	0	0
Cash, Bank	2 112 000	1 969 000	2 008 000	1 844 000
Total Current Assets	5 241 000	4 315 000	4 185 000	3 579 000
Total Assets	5 569 000	4 759 000	4 782 000	4 287 000
Total Equity	578 000	655 000	245 000	419 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	0	0	0	1 310 000
Creditors	2 272 000	2 484 000	2 081 000	1 563 000
Unpaid Taxes	452 000	543 000	546 000	486 000
Dividends	0	0	0	0
Other Current Debt	1 003 000	462 000	525 000	408 000
Total Current Debt	4 992 000	4 104 000	4 537 000	2 557 000
Total Equity and Debt	5 569 000	4 759 000	4 782 000	4 287 000

Financial indicators	2022	2021	2020	2019
Return on Equity	157,27 %	122,14 %	369,8 %	79 %
Debt-to-Equity Ratio	0	0	0	3,13
Operating Profit Margin	4,91 %	4,5 %	5,36 %	2,53 %
Current Ratio	1,05	1,05	0,92	1,4
Quick Ratio	1,62	1,73	1,36	2,69
Equity Ratio	0,1	0,14	0,05	0,1
Gross Profit Margin	27,35 %	26,68 %	26,95 %	28,92 %